Effect of omega3 on Congestive Heart Failure
Effect of Omega 3 Supplementation on Brain Natriuretic Peptide (BNP) Serum Levels Functional Capacity and Systolic and Diastolic Function of Heart Failure Patients
研究概览
详细说明
Introduction: Widely used as lipid lowering agents, Omega 3 fatty acids have been demonstrated to possess the potential to reduce the risk of cardiovascular events in patients suffering from chronic heart conditions. In this double -blinded randomized placebo-controlled clinical trial, we aim to investigate the possible beneficial effects of Omega-3 supplements on echocardiographic parameters and brain natriuretic peptide (BNP) plasma levels in patients suffering from congestive heart failure (CHF).
Methods and Materials: 100 patients with class II and III CHF, who had tri-chamber pacemaker and automated defibrillator( CRT-AICD) were initially recruited among which 70 subjects consented to participate. Subjects were randomly assigned and matched to two treatment groups. 42 patients were allocated to a two gram/day dosing of omega-3 capsule while 28 subjects were allocated to the placebo group. Demographic features and BNP plasma levels, 6-minute walk test and echocardiographic parameters of patients were recorded at baseline and at 6 months after implementation of treatment protocols. Data were further gathered and analyzed to evaluate the beneficial effects of omega-3 supplements compared to placebo.
Conclusion: Beneficial effects of Omega-3 supplementation on CHF patients were not as dramatic as initially presumed
研究类型
注册 (实际的)
阶段
- 不适用
联系人和位置
学习地点
-
-
Fars
-
Shiraz、Fars、伊朗伊斯兰共和国、55318
- Shiraz University of Medical Sciences
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
- EF< 40%
- sinus rhythm
accept randomization
- having tri-chamber pacemaker
Exclusion criteria:
- survival less than 6 months
- class IV heart failure
- using drugs other than study protocol
学习计划
研究是如何设计的?
设计细节
- 主要用途:治疗
- 分配:随机化
- 屏蔽:四人间
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
假比较器:placebo
use of placebo in control group
|
placebo given to patients
|
|
实验性的:omega 3
use of omega 3 2 gr/day for 6 months
|
use of omega 3
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
BNP level
大体时间:6 months
|
level of BNP in serum of patient prior and 6 months post recruitment
|
6 months
|
|
six minutes walk test
大体时间:6 months
|
ability to walk in six minutes after and before to syudy
|
6 months
|
|
echocardiographic data
大体时间:6 months
|
Ejection fraction Tei index Sm,Em, Am indexes of tissue doppler study
|
6 months
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
mortality
大体时间:6 months
|
any cardiac mortality in 6 months
|
6 months
|
|
hospital admission
大体时间:6 months
|
any hospital admission due to cardiac problem in 6 months
|
6 months
|
合作者和调查者
出版物和有用的链接
研究记录日期
研究主要日期
学习开始
初级完成 (实际的)
研究完成
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (估计)
研究记录更新
最后更新发布 (估计)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.